Skip to content
Roboearth – Lifestyle
Author:
Airway Therapeutics
Airway Therapeutics Awarded $1.9 Million NIH Grant to Advance Phase 2b/3 Study of Zelpultide Alfa for Prevention of Bronchopulmonary Dysplasia
September 29, 2026
Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors
April 13, 2026